Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1641900,Alcrsp11,Alcohol response QTL 11,,,alcohol metabolism trait (VT:0015089),blood ethanol level (CMO:0000535),14,80049285,115493446,Rat,n/a,region,qtl 1000,2317879,Alcrsp27,Alcohol response QTL 27,3.3,0.63,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),14,61993178,106993178,Rat,n/a,region,qtl 1000,738022,Anxrr13,Anxiety related response QTL 13,4.6,0.00039,locomotor behavior trait (VT:0001392),"number of 20 x 20 cm floor squares crossed into, out of or within a discrete space in an experimental apparatus (CMO:0001514)",1,91093646,136093646,Rat,n/a,region,qtl 1000,2313402,Anxrr24,Anxiety related response QTL 24,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),1,49147799,156446783,Rat,n/a,region,qtl 1000,2300164,Bmd44,Bone mineral density QTL 44,5.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),1,58209327,103209327,Rat,n/a,region,qtl 1000,2313098,Bmd70,Bone mineral density QTL 70,3.6,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313083,Bmd74,Bone mineral density QTL 74,4,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),1,83656882,126240667,Rat,n/a,region,qtl 1000,731168,Bp154,Blood pressure QTL 154,3.4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,100131562,236763528,Rat,n/a,region,qtl 1000,1300153,Bp171,Blood pressure QTL 171,3.37,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,94364073,153076991,Rat,n/a,region,qtl 1000,1331751,Bp199,Blood pressure QTL 199,3.60022,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,99983293,198656062,Rat,n/a,region,qtl 1000,1331793,Bp200,Blood pressure QTL 200,3.71601,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,99983293,188289386,Rat,n/a,region,qtl 1000,1549903,Bp267,Blood pressure QTL 267,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,79134941,113593716,Rat,n/a,region,qtl 1000,61342,Bp27,Blood pressure QTL 27,3.4,0.0006,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,57761301,104391981,Rat,n/a,region,qtl 1000,61344,Bp29,Blood pressure QTL 29,7.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,85779320,130779320,Rat,n/a,region,qtl 1000,2293142,Bp314,Blood pressure QTL 314,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,100354344,145354344,Rat,n/a,region,qtl 1000,7421628,Bp361,Blood pressure QTL 361,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,64588516,125875986,Rat,n/a,region,qtl 1000,10059597,Bp377,Blood pressure QTL 377,3.42,0.025,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,35377692,217372257,Rat,n/a,region,qtl 1000,70225,Bp58,Blood pressure QTL 58,3.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,34993530,173445086,Rat,n/a,region,qtl 1000,631495,Bp96,Blood pressure QTL 96,4.52,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,23406428,108057505,Rat,n/a,region,qtl 1000,1578654,Bss10,Bone structure and strength QTL 10,4,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),1,49578577,169852184,Rat,n/a,region,qtl 1000,2313072,Bss53,Bone structure and strength QTL 53,4.3,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313078,Bss54,Bone structure and strength QTL 54,3.5,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313059,Bss55,Bone structure and strength QTL 55,3.2,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313099,Bss56,Bone structure and strength QTL 56,2.4,0.0001,tibia size trait (VT:0100001),tibia midshaft endosteal cross-sectional area (CMO:0001716),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313051,Bss57,Bone structure and strength QTL 57,3.7,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313094,Bss58,Bone structure and strength QTL 58,3.7,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,43579208,126240667,Rat,n/a,region,qtl 1000,4889951,Bss92,Bone structure and strength QTL 92,3.9,,tibia area (VT:1000281),tibia-fibula cortical bone total cross-sectional area (CMO:0001721),14,87458772,106641756,Rat,n/a,region,qtl 1000,1358902,Bw47,Body weight QTL 47,1.67,,body mass (VT:0001259),body weight (CMO:0000012),1,94201400,197187904,Rat,n/a,region,qtl 1000,631213,Bw60,Body weight QTL60,4.51,,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight to body weight ratio (CMO:0000635),14,85307663,106641756,Rat,n/a,region,qtl 1000,724529,Cm16,Cardiac mass QTL 16,2.7,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),1,90804143,161321256,Rat,n/a,region,qtl 1000,1578780,Cm52,Cardiac mass QTL 52,3.3,0.0001,heart mass (VT:0007028),heart wet weight (CMO:0000069),1,82788437,239853971,Rat,n/a,region,qtl 1000,9589034,Epfw11,Epididymal fat weight QTL 11,6,0.001,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),14,60980905,105980905,Rat,n/a,region,qtl 1000,2300324,Fetw1,Fetal weight QTL 1,12.1,0.005,fetal growth trait (VT:0004201),fetal body weight (CMO:0002080),1,88634585,106002500,Rat,n/a,region,qtl 1000,1582234,Gluco18,Glucose level QTL 18,3.4,0.0003,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,85917265,130917265,Rat,n/a,region,qtl 1000,1582209,Gluco20,Glucose level QTL 20,3.8,0.0005,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),14,78172765,102549388,Rat,n/a,region,qtl 1000,1582236,Gluco22,Glucose level QTL 22,3.3,0.0164,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),14,78172765,102549388,Rat,n/a,region,qtl 1000,1582259,Gluco23,Glucose level QTL 23,3.1,0.0008,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),14,80049285,115493446,Rat,n/a,region,qtl 1000,1582250,Gluco26,Glucose level QTL 26,3.3,0.0009,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),14,78172765,106641756,Rat,n/a,region,qtl 1000,1582197,Gluco27,Glucose level QTL 27,3.4,0.0006,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),14,78172765,102549388,Rat,n/a,region,qtl 1000,1582255,Gluco29,Glucose level QTL 29,3.1,0.0025,blood glucose amount (VT:0000188),absolute change in blood glucose level area under curve (CMO:0002034),14,78172765,102549388,Rat,n/a,region,qtl 1000,10054135,Gmadr2,Adrenal mass QTL 2,1.97,0.0129,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),1,83502376,128502376,Rat,n/a,region,qtl 1000,634328,Hc5,Hypercalciuria QTL 5,2.3,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),14,63548095,108548095,Rat,n/a,region,qtl 1000,631688,Hcas2,Hepatocarcinoma susceptibility QTL 2,3,0.0001,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,5655769,122614963,Rat,n/a,region,qtl 1000,1300121,Hrtrt1,Heart rate QTL 1,3.7,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,66113339,122614963,Rat,n/a,region,qtl 1000,1331749,Hrtrt11,Heart rate QTL 11,2.973,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,99983293,216213510,Rat,n/a,region,qtl 1000,2298545,Neuinf8,Neuroinflammation QTL 8,4.6,,nervous system integrity trait (VT:0010566),spinal cord beta-2 microglobulin mRNA level (CMO:0002125),1,58354072,161711996,Rat,n/a,region,qtl 1000,70209,Niddm23,Non-insulin dependent diabetes mellitus QTL 23,2.82,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,99983293,216325819,Rat,n/a,region,qtl 1000,631839,Niddm37,Non-insulin dependent diabetes mellitus QTL 37,3.37,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),14,12680424,106641756,Rat,n/a,region,qtl 1000,634314,Niddm44,Non-insulin dependent diabetes mellitus QTL 44,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,49578693,217054291,Rat,n/a,region,qtl 1000,631523,Pia13,Pristane induced arthritis QTL 13,3.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),14,42442731,108833671,Rat,n/a,region,qtl 1000,1300136,Rf22,Renal function QTL 22,3.9,,renal blood flow trait (VT:2000006),absolute change in renal vascular resistance (CMO:0001900),14,43910761,105074364,Rat,n/a,region,qtl 1000,1302788,Scl19,Serum cholesterol QTL 19,4.6,0.001,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),1,94225372,130917265,Rat,n/a,region,qtl 1000,1331800,Scl25,Serum cholesterol level QTL 25,3.013,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),1,99983293,127203999,Rat,n/a,region,qtl 1000,1549834,Scl45,Serum cholesterol level QTL 45,5.8,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),14,51818462,105074364,Rat,n/a,region,qtl 1000,2300197,Scl59,Serum cholesterol level QTL 59,,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),14,78446303,110402569,Rat,n/a,region,qtl 1000,4889494,Scort2,Serum corticosterone level QTL 2,4.2,,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),1,86776571,131776571,Rat,n/a,region,qtl 1000,1358359,Sradr1,Stress Responsive Adrenal Weight QTL 1,4.74,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),1,25951907,130917265,Rat,n/a,region,qtl 1000,7411712,Strs4,Sensitivity to stroke QTL 4,8.7,,cerebrum integrity trait (VT:0010549),percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932),1,79689548,124689548,Rat,n/a,region,qtl 1000,724567,Tcas6,Tongue tumor susceptibility QTL 6,6.85,,tongue integrity trait (VT:0010553),number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950),1,95304961,156446783,Rat,n/a,region,qtl 1000,724521,Uae1,Urinary albumin excretion QTL 1,3.8,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,94201400,184846632,Rat,n/a,region,qtl 1000,9590294,Uminl4,Urine mineral level QTL 4,5.66,0.001,urine mineral amount (VT:0015086),urine electrolyte level (CMO:0000593),14,60980905,105980905,Rat,n/a,region,qtl